Zheng Shuai, Li Shuang, Zhang Duo, Zhang Xindan, Zhou Di, Hou Qinlong, Li Gen, Han Huiming
Beihua University, The School of Basic Medicine, Jilin, China.
Beihua University, The Center for Infection and lmmunity, Jilin, China.
J Antibiot (Tokyo). 2025 Aug 27. doi: 10.1038/s41429-025-00860-5.
Klebsiella pneumoniae is a ubiquitous Gram-negative pathogen in clinical settings, responsible for pulmonary infections, urinary tract infections, septicemia, and other severe diseases.Over recent years, widespread use of aminoglycosides, quinolones, and β-lactams has driven a marked increase in antimicrobial resistance, compromising treatment efficacy. Here, we review the molecular bases of K. pneumoniae drug resistance, focusing on β-lactamase production, efflux-pump overexpression, target-site modifications, and reduced membrane permeability. We also examine the horizontal spread of resistance determinants via plasmids, integrons, and transposons. By integrating these mechanisms with their transmission pathways, this review provides a comprehensive framework to inform rational antibiotic selection, guide infection-control policies, and support the development of novel anti-resistance strategies.
肺炎克雷伯菌是临床环境中一种普遍存在的革兰氏阴性病原体,可导致肺部感染、尿路感染、败血症和其他严重疾病。近年来,氨基糖苷类、喹诺酮类和β-内酰胺类药物的广泛使用导致抗菌药物耐药性显著增加,影响了治疗效果。在此,我们综述肺炎克雷伯菌耐药性的分子基础,重点关注β-内酰胺酶的产生、外排泵的过表达、靶点修饰以及膜通透性降低。我们还研究了耐药决定因素通过质粒、整合子和转座子的水平传播。通过将这些机制与其传播途径相结合,本综述提供了一个全面的框架,为合理选择抗生素、指导感染控制政策以及支持新型抗耐药策略的开发提供依据。